1-naphthylamine has been researched along with Disease Models, Animal in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Grunnet, M; Jespersen, T; Lubberding, AF; Sattler, SM; Sørensen, US; Tfelt-Hansen, J | 1 |
| Fleig, A; Penner, R; Suzuki, S | 1 |
| Chubanov, V; Gudermann, T | 1 |
| Amado, F; Cabral, S; Castellanos, E; Colaço, B; Costa, C; Duarte, JA; Ferreira, R; Márquez, M; Moreira-Gonçalves, D; Neuparth, MJ; Oliveira, P; Padrão, AI; Pires, MJ; Santos, LL; Teixeira, C; Vitorino, R | 1 |
| Aflaki, M; Brundel, BJ; Diness, JG; Dobrev, D; Grunnet, M; Harada, M; Huang, H; Nattel, S; Naud, P; Qi, XY; Wu, CT; Zhou, XB | 1 |
| Buhl, R; Carstensen, H; Diness, JG; Flethøj, M; Grunnet, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Pehrson, S; Præstegaard, KF; Sørensen, US | 1 |
| Diness, JG; Grunnet, M; Jespersen, T; Kirchhoff, JE; Sheykhzade, M | 1 |
| Bezprozvanny, IB; Egorova, PA; Vlasova, OL; Zakharova, OA | 1 |
| Bae, S; Choi, JH; Choudhury, S; Kang, PM; Ke, Q; Koh, YY; Siu, PM | 1 |
| Alcala, MA; Bartlett, DL; Kwan, SY; Lang, M; Lee, YJ; Petoud, S; Shade, CM; Uh, H; Wang, M; Weber, SG | 1 |
| Diness, JG; Grunnet, M; Hansen, RS; Skibsbye, L; Sørensen, US | 1 |
| Bartels, ED; Diness, JG; Grunnet, M; Hansen, RS; Jespersen, T; Skibsbye, L; Sørensen, US | 1 |
| Overstreet, DH; Pucilowski, O | 1 |
| Kriete, M; Rapoport, JL; Ryland, DH | 1 |
1 review(s) available for 1-naphthylamine and Disease Models, Animal
| Article | Year |
|---|---|
Mapping TRPM7 Function by NS8593.
Topics: 1-Naphthylamine; Animals; Disease Models, Animal; Humans; Ion Channel Gating; Protein Serine-Threonine Kinases; TRPM Cation Channels | 2020 |
1 trial(s) available for 1-naphthylamine and Disease Models, Animal
| Article | Year |
|---|---|
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Diseases; Dogs; Double-Blind Method; Fenfluramine; Fluoxetine; Follow-Up Studies; Grooming; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Ulcer | 1992 |
12 other study(ies) available for 1-naphthylamine and Disease Models, Animal
| Article | Year |
|---|---|
Arrhythmia development during inhibition of small-conductance calcium-activated potassium channels in acute myocardial infarction in a porcine model.
Topics: 1-Naphthylamine; Animals; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Heart Ventricles; Myocardial Infarction; Small-Conductance Calcium-Activated Potassium Channels; Swine; Tachycardia, Ventricular | 2019 |
TRPM7 contributes to progressive nephropathy.
Topics: 1-Naphthylamine; Animals; Disease Models, Animal; Fibrosis; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Signal Transduction; Transforming Growth Factor beta1; TRPM Cation Channels; Ureteral Obstruction | 2020 |
Bladder cancer-induced skeletal muscle wasting: disclosing the role of mitochondria plasticity.
Topics: 1-Naphthylamine; Animals; Apoptosis Regulatory Proteins; Boronic Acids; C-Reactive Protein; Cytokine TWEAK; Disease Models, Animal; Interleukin-1beta; Lactic Acid; Male; Membrane Proteins; Mitochondria, Muscle; Muscle, Skeletal; Muscular Atrophy; Myostatin; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors; Urinary Bladder Neoplasms; Urothelium | 2013 |
Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog.
Topics: 1-Naphthylamine; Animals; Atrial Fibrillation; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Electrophysiological Phenomena; Heart Atria; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channel Blockers; Pulmonary Veins; Small-Conductance Calcium-Activated Potassium Channels | 2014 |
Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.
Topics: 1-Naphthylamine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Heart Atria; Horses; Immunohistochemistry; Microscopy, Confocal; Models, Anatomic; Myocytes, Cardiac; Small-Conductance Calcium-Activated Potassium Channels; Treatment Outcome | 2015 |
Antiarrhythmic Effect of Either Negative Modulation or Blockade of Small Conductance Ca2+-activated K+ Channels on Ventricular Fibrillation in Guinea Pig Langendorff-perfused Heart.
Topics: 1-Naphthylamine; Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Female; Guinea Pigs; In Vitro Techniques; Isolated Heart Preparation; Potassium Channel Blockers; Small-Conductance Calcium-Activated Potassium Channels; Ventricular Fibrillation | 2015 |
In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.
Topics: 1-Naphthylamine; Action Potentials; Aging; Animals; Chlorzoxazone; Disease Models, Animal; Injections, Intraperitoneal; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Microelectrodes; Neurotransmitter Agents; Purkinje Cells; Small-Conductance Calcium-Activated Potassium Channels; Spinocerebellar Ataxias | 2016 |
Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA.
Topics: 1-Naphthylamine; Animals; Apoptosis; Apoptosis Inducing Factor; Caspase Inhibitors; Caspases; Disease Models, Animal; Doxorubicin; Heart Failure; Male; Mice; Mice, Transgenic; Mitochondria, Heart; Naphthalimides; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Serpins; Viral Proteins | 2010 |
Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.
Topics: 1-Naphthylamine; Animals; Catheterization; Cell Line, Tumor; Colorectal Neoplasms; Dendrimers; Diagnostic Imaging; Disease Models, Animal; Europium; Liver; Liver Neoplasms; Luminescence; Nanoparticles; Naphthalimides; Particle Size; Quinolones; Rats; Time Factors | 2011 |
The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.
Topics: 1-Naphthylamine; Alkanes; Anesthesia; Animals; Anti-Arrhythmia Agents; Apamin; Atrial Fibrillation; Cardiac Pacing, Artificial; Disease Models, Animal; Dose-Response Relationship, Drug; Insect Proteins; Male; Molecular Targeted Therapy; Potassium Channel Blockers; Quinolinium Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Reaction Time; Small-Conductance Calcium-Activated Potassium Channels; Time Factors | 2011 |
Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition.
Topics: 1-Naphthylamine; Age Factors; Alkanes; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Disease Models, Animal; Humans; Hypertension; Injections, Intravenous; Male; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Quinolinium Compounds; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity; Time Factors | 2011 |
Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains.
Topics: 1-Naphthylamine; Animals; Apomorphine; Body Temperature Regulation; Breeding; Depressive Disorder; Desipramine; Disease Models, Animal; Male; Motor Activity; Parasympathetic Nervous System; Rats; Sertraline; Time Factors | 1993 |